Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-000501
Filing Date
2020-02-26
Accepted
2020-02-26 19:03:28
Documents
1
Period of Report
2020-02-25

Document Format Files

Seq Description Document Type Size
1 form4-02262020_040214.html 4  
1 form4-02262020_040214.xml 4 6972
  Complete submission text file 0001415889-20-000501.txt   8627
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O RADIUS HEALTH, INC. 201 BROADWAY, 6TH FLOOR CAMBRIDGE MA 02139
Business Address
Williams Gregory C. (Reporting) CIK: 0001597293 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 20657801